Article info
PDFNeurological rarities
Focal inhibitory seizures: a cause of recurrent transient weakness
- Correspondence to Fahmida A Chowdhury, Department of Neurology, St Thomas’ Hospital, Westminster Bridge Road, London SE1 7EH, UK; fahmidachowdhury{at}hotmail.com
Citation
Focal inhibitory seizures: a cause of recurrent transient weakness
Publication history
- Accepted July 13, 2015
- First published August 5, 2015.
Online issue publication
February 26, 2018
Article Versions
- Previous version (14 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Other content recommended for you
- The neurofibromatoses
- Genetic Severity Score predicts clinical phenotype in NF2
- Diagnosis of sporadic neurofibromatosis type 2 in the paediatric population
- Neurofibromatosis type 2
- Cranial meningiomas in 411 neurofibromatosis type 2 (NF2) patients with proven gene mutations: clear positional effect of mutations, but absence of female severity effect on age at onset
- Schwannomatosis: a genetic and epidemiological study
- Multiple meningiomas: differential involvement of the NF2 gene in children and adults
- Paediatric presentation of type 2 neurofibromatosis
- Revisiting the UK Genetic Severity Score for NF2: a proposal for the addition of a functional genetic component
- Probability of bilateral disease in people presenting with a unilateral vestibular schwannoma